Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M49,912Revenue $M19,652Net Margin (%)8.1Altman Z-Score2.3
Enterprise Value $M56,383EPS $1.8Operating Margin %9.9Piotroski F-Score6
P/E(ttm)30.3Beneish M-Score--Pre-tax Margin (%)12.0Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %11.2Quick Ratio1.1Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %2.5Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-7.0ROA % (ttm)3.2Higher Current Ratio y-yY
Dividend Yield %2.5PEG12.5ROE % (ttm)6.5Less Shares Outstanding y-yN
Payout Ratio %75.0Shares Outstanding M908ROIC % (ttm)2.8Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVAJulian Robertson 2015-12-31 Buy 5.04%$55.96 - $66.32
($61.94)
$ 55.81-10%New holding595,300
TEVAJohn Paulson 2015-12-31 Add0.97%$55.96 - $66.32
($61.94)
$ 55.81-10%Add 13.39%20,409,300
TEVANWQ Managers 2015-12-31 Reduce-0.89%$55.96 - $66.32
($61.94)
$ 55.81-10%Reduce -42.70%1,380,143
TEVAVanguard Health Care Fund 2015-12-31 Buy 0.76%$55.96 - $66.32
($61.94)
$ 55.81-10%New holding5,800,000
TEVADavid Dreman 2015-12-31 Sold Out -0.24%$55.96 - $66.32
($61.94)
$ 55.81-10%Sold Out0
TEVAFirst Eagle Investment 2015-12-31 Reduce-0.01%$55.96 - $66.32
($61.94)
$ 55.81-10%Reduce -2.14%4,371,619
TEVABarrow, Hanley, Mewhinney & Strauss 2015-12-31 Add0.01%$55.96 - $66.32
($61.94)
$ 55.81-10%Add 0.84%9,602,463
TEVAJohn Keeley 2015-12-31 Add$55.96 - $66.32
($61.94)
$ 55.81-10%Add 1.10%36,385
TEVAJohn Paulson 2015-09-30 Add4.82%$55.08 - $72
($64.84)
$ 55.81-14%Add 786.48%18,000,000
TEVANWQ Managers 2015-09-30 Reduce-0.46%$55.08 - $72
($64.84)
$ 55.81-14%Reduce -19.29%2,408,826
TEVAGeorge Soros 2015-09-30 Sold Out -0.26%$55.08 - $72
($64.84)
$ 55.81-14%Sold Out0
TEVADavid Dreman 2015-09-30 Reduce-0.23%$55.08 - $72
($64.84)
$ 55.81-14%Reduce -52.52%42,892
TEVAFirst Eagle Investment 2015-09-30 Add0.1%$55.08 - $72
($64.84)
$ 55.81-14%Add 18.90%4,467,011
TEVABarrow, Hanley, Mewhinney & Strauss 2015-09-30 Reduce-0.03%$55.08 - $72
($64.84)
$ 55.81-14%Reduce -3.45%9,522,401
TEVARonald Muhlenkamp 2015-09-30 Add$55.08 - $72
($64.84)
$ 55.81-14%Add 0.02%176,955
TEVAJohn Keeley 2015-09-30 Reduce$55.08 - $72
($64.84)
$ 55.81-14%Reduce -0.80%35,990
TEVAJohn Paulson 2015-06-30 Buy 0.57%$58.91 - $67.14
($61.7)
$ 55.81-10%New holding2,030,500
TEVANWQ Managers 2015-06-30 Reduce-0.53%$58.91 - $67.14
($61.7)
$ 55.81-10%Reduce -18.66%2,984,606
TEVAGeorge Soros 2015-06-30 Buy 0.26%$58.91 - $67.14
($61.7)
$ 55.81-10%New holding423,308
TEVAVanguard Health Care Fund 2015-06-30 Sold Out -0.25%$58.91 - $67.14
($61.7)
$ 55.81-10%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    John Keeley Comments on Teva Pharmaceuticals Apr 26 2016 
    Pfizer-Allergen Merger Deal End Hurts Some Funds But Helps Many Apr 08 2016 
    Time To Buy Allergan Apr 06 2016 
    Health Care Investor Larry Robbins Buys HCA Holdings, Cigna Mar 31 2016 
    Fight Market Malaise with These Four Sector Strategies Mar 30 2016 
    Bernard Horn Comments on Teva Pharmaceutical Mar 21 2016 
    Polaris Global Value Fund Annual Letter 2015 Mar 21 2016 
    John Paulson Raises Stake in Valeant, Teva Pharmaceutical Mar 18 2016 
    Andreas Halvorsen Raises Stake in Teva Pharmaceutical Mar 09 2016 
    Julian Robertson Buys 8 New Stakes in 4th Quarter Mar 09 2016 

    More From Other Websites
    Major Pharma Short Interest Remains Mixed, With 1 Massive Drop Apr 27 2016
    Teva migraine awareness campaign features Hollywood actress Apr 26 2016
    Jennifer Morrison Reveals How Her Journey with Migraine is More Than a Headache Apr 25 2016
    Goldman Sach's 5 Large-Cap Pharma Stock Favorites Ahead of Earnings Apr 25 2016
    A Look at Zach Schreiber’s Top Picks Ahead of His Ira Sohn Presentation Apr 21 2016
    Teva to Report First Quarter 2016 Financial Results on May 9, 2016 Apr 18 2016
    Teva Presents New Data for SD-809 in Huntington Disease at 68th American Academy of Neurology (AAN)... Apr 18 2016
    Allergan's Outlook Brightens as Generics Sale Seems on Track Apr 15 2016
    Why Has Teva Pharmaceutical Targeted Orphan Diseases? Apr 14 2016
    CIO Voices: Allergan's Sean Lennon Says Never Presume Job Security in a Merger Apr 13 2016
    Teva Pharmaceutical: Label Expansion Plans in 2016 Apr 13 2016
    You Can’t Smooth The Bumps Apr 12 2016
    Short Sellers Become More Selective in Major Pharma Apr 12 2016
    Teva to Present Data Highlighting Company’s Pipeline in Neurological Disorders at 68th AAN Annual... Apr 12 2016
    [$$] Four Buys After the Specialty-Pharma Selloff Apr 08 2016
    Israel Remains A Developed Market Opportunity Apr 08 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)